Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome
- PMID: 10204841
- PMCID: PMC1734331
Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome
Abstract
We report on the evaluation of a strategy for screening for XNP/ATR-X mutations in males with mental retardation and associated dysmorphology. Because nearly half of the mutations in this gene reported to date fall into a short 300 bp region of the transcript, we decided to focus in this region and to extend the mutation analysis to cases with a negative family history. This study includes 21 mentally retarded male patients selected because they had severe mental retardation and a typical facial appearance. The presence of haemoglobin H or urogenital abnormalities was not considered critical for inclusion in this study. We have identified six mutations which represents a mutation detection rate of 28%. This figure is high enough for us to propose this strategy as a valid first level of screening in a selected subset of males with mental retardation. This approach is simple, does not require RNA preparation, does not involve time consuming mutation detection methods, and can thus be applied to a large number of patients at a low cost in any given laboratory.
Similar articles
-
Determination of the genomic structure of the XNP/ATRX gene encoding a potential zinc finger helicase.Genomics. 1997 Jul 15;43(2):149-55. doi: 10.1006/geno.1997.4793. Genomics. 1997. PMID: 9244431
-
Molecular genetic study of japanese patients with X-linked alpha-thalassemia/mental retardation syndrome (ATR-X).Am J Med Genet. 2000 Sep 18;94(3):242-8. Am J Med Genet. 2000. PMID: 10995512
-
Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without alpha-thalassemia.Am J Hum Genet. 1996 Mar;58(3):499-505. Am J Hum Genet. 1996. PMID: 8644709 Free PMC article.
-
Alpha-thalassemia intellectual disability: variable phenotypic expression among males with a recurrent nonsense mutation - c.109C>T (p.R37X).Clin Genet. 2015 May;87(5):461-6. doi: 10.1111/cge.12420. Epub 2014 May 30. Clin Genet. 2015. PMID: 24805811 Review.
-
Molecular-clinical spectrum of the ATR-X syndrome.Am J Med Genet. 2000 Fall;97(3):204-12. doi: 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X. Am J Med Genet. 2000. PMID: 11449489 Review.
Cited by
-
SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome.Int J Mol Sci. 2018 Sep 18;19(9):2811. doi: 10.3390/ijms19092811. Int J Mol Sci. 2018. PMID: 30231518 Free PMC article.
-
Aberrant calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain.J Neurosci. 2011 Jan 5;31(1):346-58. doi: 10.1523/JNEUROSCI.4816-10.2011. J Neurosci. 2011. PMID: 21209221 Free PMC article.
-
Fragile X and X-linked intellectual disability: four decades of discovery.Am J Hum Genet. 2012 Apr 6;90(4):579-90. doi: 10.1016/j.ajhg.2012.02.018. Am J Hum Genet. 2012. PMID: 22482801 Free PMC article. Review.
-
Identification of a Hemizygous Novel Splicing Variant in ATRX Gene: A Case Report and Literature Review.Front Pediatr. 2022 Apr 4;10:834087. doi: 10.3389/fped.2022.834087. eCollection 2022. Front Pediatr. 2022. PMID: 35444965 Free PMC article.
-
The Multiple Facets of ATRX Protein.Cancers (Basel). 2021 May 5;13(9):2211. doi: 10.3390/cancers13092211. Cancers (Basel). 2021. PMID: 34062956 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous